Visualizar Tese - Instituto de Biociências - Unesp
Visualizar Tese - Instituto de Biociências - Unesp Visualizar Tese - Instituto de Biociências - Unesp
Cirilo, PDRREFERÊNCIAS231Watanabe Y and Maekawa M. Methylation of DNA in cancer. Adv Clin Chem, 52, 145-167, 2010.Waugh DJ and Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res, 14, 6735-6741,2008.Wei LH, Torng PL, Hsiao SM et al. Histone Deacetylase 6 Regulates Estrogen Receptor {alpha} inUterine Leiomyoma. Reprod Sci, Epub ahead of print, 2011.Weston G, Trajstman AC, Gargett CE et al. Fibroids display an anti-angiogenic gene expressionprofile when compared with adjacent myometrium. Mol Hum Reprod, 9, 541–549, 2003.Wheeler DA, Srinivasan M, Egholm M et al. The complete genome of an individual by massivelyparallel DNA sequencing. Nature, 452, 872-876, 2008.WHO Consultation on obesity. Geneva: World Health Organ, 1997.Williams AJ, Powell WL, Collins, T et al. HMGI(Y) expression in human uterine leiomyomata.Involvement of another high-mobility group architectural factor in a benign neoplasm. Am JPathol, 150, 911-918, 1997.Wolverton T and Lalande M. Identification and characterization of three members of a novelsubclass of protocadherins. Genomics, 66-72, 2001.Wong KK, de Leeuw RJ, Dosanjh NS et al: A comprehensive analysis of common copy-numbervariations in the human genome. Am J Hum Genet, 80, 91–104, 2007.Wu CL, Classon M, Dyson N et al. Expression of dominant-negative mutant DP-1 blocks cell cycleprogression in G1. Mol Cell Biol, 16, 3698-3706, 1996.Wu T, Chen X, Xie L. Selective estrogen receptor modulators (SERMs) for uterine leiomyomas.Cochrane Database Syst Rev, 17, CD005287, 2007.Wu X, Blanck A, Olovsson M et al. Expression of basic fibroblast growth factor (bFGF), FGF receptor1 and FGF receptor 2 in uterine leiomyomas and myometrium during the menstrual cycle,after menopause and GnRHa treatment. Acta Obstet Gynecol Scand, 80, 497-504, 2001.Xiao HL, Eyden B, Yan XC et al. Intraparenchymal myofibromatosis of the brain in an adult: report ofan unusual case. Neuropathology, 30, 288-293, 2010.Xiao J, Liu CC, Chen PL et al. RINT-1, a novel Rad50-interacting protein, participates in radiationinducedG(2)/M checkpoint control. J Biol Chem, 276, 6105-6111 2001.Xie Y, Yang D, He Q et al. Zebrafish as a model system to study the physiological function oftelomeric protein TPP1. PLoS One, 6, e16440, 2011.Xing YP, Powell WL, Morton CC. The del(7) subgroup in Uterine Leiomyomata: genetic and biologiccharacteristics. Cancer Genet Cytogenet, 98, 69-74, 1997.Xu Q, Takekida S, Ohara N et al. Progesterone receptor modulator CDB-2914 down-regulatesproliferative cell nuclear antigen and Bcl-2 protein expression and up-regulates caspase-3
Cirilo, PDRREFERÊNCIAS232and poly(adenosine 5'-diphosphate-ribose) polymerase expression in cultured humanuterine leiomyoma cells. J Clin Endocrinol Metab, 90, 953-961, 2005.Xu Y, Jing Y, Ma S et al. Primary angioleiomyoma in the sellar region: a case report and literaturereview. Clin Neuropathol, 29, 21-25, 2010.Yen-Ping HJ, Man WC, Wen Y et al. Transforming growth interacting factor expression in leiomyomacompared with myometrium. Fertil Steril, 94, 1078-1083, 2010.Ying J, Li H, Seng TJ et al. Functional epigenetics identifies a protocadherin PCDH10 as a candidatetumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas withfrequent methylation. Oncogene, 25, 1070-1080, 2006.Yoshida S, Ohara N, Xu Q et al. Cell-type specific actions of progesterone receptor modulators in theregulation of uterine leiomyoma growth. Semin Reprod Med, 28, 260-273, 2010.Young A. Receptor pharmacology. Adv Pharmacol, 52, 47-65, 2005.Yu H and Rohan T. Role of the insulin-like growth factor family in cancer development andprogression. J Natl Cancer Inst, 92, 1472–1489, 2000.Yu W, Kanaan Y, Bae YK et al. Chromosomal changes in aggressive breast cancers with basal-likefeatures. Cancer Genet Cytogenet, 193, 29–37, 2009.Zaitseva M, Vollenhoven BJ, Rogers PAW. In vitro culture significantly alters gene expressionprofiles and reduces differences between myometrial and fibroid smooth muscle cells. MolHum Reprod, 12, 187–207, 2006.Zaloudek CJ and Norris HJ. Mesenchymal tumors of the uterus. In: Fenoglio CM, Wolff M, eds. ProgSurg Pathol 3th ed. New York: Masson, 35pp, 1981.Zasławski R, Surowiak P, Dziegiel P et al. Analysis of the expression of estrogen and progesteronreceptors, and of PCNA and Ki67 proliferation antigens, in uterine myomata cells in relationto the phase of the menstrual cycle. Med Sci Monit, 7, 908-913, 2001.Zavadil J, Ye H, Liu Z et al. Profiling and Functional Analyses of MicroRNAs and Their Target GeneProducts in Human Uterine Leiomyomas. PLoS ONE, 5, e12362, 2010.Zeng WR, Scherer SW, Koutsilieris M et al. Loss of heterozygosity and reduced expression of theCUTL1 gene in uterine leiomyomas. Oncogene, 14, 2355-2365, 1997.Zhang XY, Shi L, Liu Y et al. ICPS: an integrative cancer profiler system. Bioinformatics, 26, 2649-2650, 2010.Zheng HC, Wei ZL, Xu XY et al. Parafibromin expression is an independent prognostic factor forcolorectal carcinomas. Hum Pathol, Epub ahead of print, 2011.Zydan HLS, Fagundes DJ, Sória-Vieira S et al. Hysterectomy and benign gynecological diseases: whathas been performed in Medical Residency in Brazil? Rev Bras Ginecol Obstet, 29, 67-73,2007.
- Page 203 and 204: Cirilo, PDRDISCUSSÃO180proliferati
- Page 205 and 206: Cirilo, PDRDISCUSSÃO182Entre os 20
- Page 207 and 208: Cirilo, PDRDISCUSSÃO184propôs um
- Page 209 and 210: Cirilo, PDRDISCUSSÃO186analisados
- Page 211 and 212: Cirilo, PDRDISCUSSÃO188observados
- Page 213 and 214: Cirilo, PDRDISCUSSÃO190moduladores
- Page 215 and 216: Cirilo, PDRDISCUSSÃO192genômica/d
- Page 217 and 218: Cirilo, PDRDISCUSSÃO194identificar
- Page 219 and 220: Cirilo, PDRDISCUSSÃO196e também d
- Page 221 and 222: Cirilo, PDRDISCUSSÃO198O gene COL3
- Page 223 and 224: Cirilo, PDRDISCUSSÃO200resistênci
- Page 225 and 226: Cirilo, PDRDISCUSSÃO202bioquímica
- Page 227 and 228: Cirilo, PDRDISCUSSÃO204carcinoma c
- Page 229 and 230: Cirilo, PDRCONCLUSÕES DISCUSSÃO20
- Page 231 and 232: Cirilo, PDRREFERÊNCIAS2087. Refer
- Page 233 and 234: Cirilo, PDRREFERÊNCIAS210Brazelle
- Page 235 and 236: Cirilo, PDRREFERÊNCIAS212Churikov
- Page 237 and 238: Cirilo, PDRREFERÊNCIAS214Gannon BR
- Page 239 and 240: Cirilo, PDRREFERÊNCIAS216Holthause
- Page 241 and 242: Cirilo, PDRREFERÊNCIAS218Kazmiercz
- Page 243 and 244: Cirilo, PDRREFERÊNCIAS220Lloret M,
- Page 245 and 246: Cirilo, PDRREFERÊNCIAS222Mitra R,
- Page 247 and 248: Cirilo, PDRREFERÊNCIAS224Ozisik YY
- Page 249 and 250: Cirilo, PDRREFERÊNCIAS226Redon R,
- Page 251 and 252: Cirilo, PDRREFERÊNCIAS228Solyom S,
- Page 253: Cirilo, PDRREFERÊNCIAS230Ueki K, R
- Page 257 and 258: Skubitz KM e Skubitz APJ Lab Clin M
- Page 259 and 260: Dimitrova IK et al. Fertil Steril,9
- Page 261 and 262: 317T_B317T_C13 614T 44 LU prolifera
- Page 263 and 264: 46 867T 46 LUM outros B 14 33,5 17
- Page 265 and 266: 1015T 6q13-q14.1 75,806,978-76,314,
- Page 267 and 268: MRPS31, SLC25A15, SUGT1L1 320d-1630
- Page 269 and 270: 8q22.3-q23.1 105,831,966 107,742,33
- Page 271 and 272: Anexo 5. Genes identificados na an
- Page 273 and 274: + + CCDC8 0 51 37 14+ - CALM3 51 0
- Page 275 and 276: ABSTRACTBackground: Uterine leiomyo
- Page 277 and 278: Thus, these findings prompt us to i
- Page 279 and 280: Technologies, Santa Clara, CA). Sta
- Page 281 and 282: mapped at 1p36.13, 1q41, 2q32.1, 2q
- Page 283 and 284: genetic disorder showed the higher
- Page 285 and 286: The modulators were mainly associat
- Page 287 and 288: egulation of cell cycle. Chegini an
- Page 289 and 290: REFERENCES[1] Baird DD, Dunson DB (
- Page 291 and 292: [37] Luo X, Ding L, Xu J et al. (20
- Page 293 and 294: AArray CGHExpression arrayBtumoral
- Page 295 and 296: ABDiseases and Disorders P value Mo
- Page 298 and 299: Tabel 2. Genes identified on module
- Page 300 and 301: Table S1. Clinical parameters and h
- Page 302 and 303: 32 954T 45 M secretory W 12 33,7 18
Cirilo, PDRREFERÊNCIAS231Watanabe Y and Maekawa M. Methylation of DNA in cancer. Adv Clin Chem, 52, 145-167, 2010.Waugh DJ and Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res, 14, 6735-6741,2008.Wei LH, Torng PL, Hsiao SM et al. Histone Deacetylase 6 Regulates Estrogen Receptor {alpha} inUterine Leiomyoma. Reprod Sci, Epub ahead of print, 2011.Weston G, Trajstman AC, Gargett CE et al. Fibroids display an anti-angiogenic gene expressionprofile when compared with adjacent myometrium. Mol Hum Reprod, 9, 541–549, 2003.Wheeler DA, Srinivasan M, Egholm M et al. The complete genome of an individual by massivelyparallel DNA sequencing. Nature, 452, 872-876, 2008.WHO Consultation on obesity. Geneva: World Health Organ, 1997.Williams AJ, Powell WL, Collins, T et al. HMGI(Y) expression in human uterine leiomyomata.Involvement of another high-mobility group architectural factor in a benign neoplasm. Am JPathol, 150, 911-918, 1997.Wolverton T and Lalan<strong>de</strong> M. I<strong>de</strong>ntification and characterization of three members of a novelsubclass of protocadherins. Genomics, 66-72, 2001.Wong KK, <strong>de</strong> Leeuw RJ, Dosanjh NS et al: A comprehensive analysis of common copy-numbervariations in the human genome. Am J Hum Genet, 80, 91–104, 2007.Wu CL, Classon M, Dyson N et al. Expression of dominant-negative mutant DP-1 blocks cell cycleprogression in G1. Mol Cell Biol, 16, 3698-3706, 1996.Wu T, Chen X, Xie L. Selective estrogen receptor modulators (SERMs) for uterine leiomyomas.Cochrane Database Syst Rev, 17, CD005287, 2007.Wu X, Blanck A, Olovsson M et al. Expression of basic fibroblast growth factor (bFGF), FGF receptor1 and FGF receptor 2 in uterine leiomyomas and myometrium during the menstrual cycle,after menopause and GnRHa treatment. Acta Obstet Gynecol Scand, 80, 497-504, 2001.Xiao HL, Ey<strong>de</strong>n B, Yan XC et al. Intraparenchymal myofibromatosis of the brain in an adult: report ofan unusual case. Neuropathology, 30, 288-293, 2010.Xiao J, Liu CC, Chen PL et al. RINT-1, a novel Rad50-interacting protein, participates in radiationinducedG(2)/M checkpoint control. J Biol Chem, 276, 6105-6111 2001.Xie Y, Yang D, He Q et al. Zebrafish as a mo<strong>de</strong>l system to study the physiological function oftelomeric protein TPP1. PLoS One, 6, e16440, 2011.Xing YP, Powell WL, Morton CC. The <strong>de</strong>l(7) subgroup in Uterine Leiomyomata: genetic and biologiccharacteristics. Cancer Genet Cytogenet, 98, 69-74, 1997.Xu Q, Takekida S, Ohara N et al. Progesterone receptor modulator CDB-2914 down-regulatesproliferative cell nuclear antigen and Bcl-2 protein expression and up-regulates caspase-3